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Introduction
Many studies have been performed to minimize respiratory organ motion and consequent dosimetric errors in radiation treatment. The real-time position management (RPM) gating system (Varian Medical Systems, Palo Alto, CA) has been used effectively in many clinical sites. This system only irradiates tumors in a specified respiratory phase region and uses an infrared reflective marker block placed on the patient's abdomen as an indicator of tumor motion. It has also been used in intensity modulated radiation therapy (IMRT), [1] [2] [3] [4] and many clinics perform the gating method in volumetric modulated arc therapy (VMAT) with RapidArc (Varian Medical Systems, Palo Alto, CA) to reduce the respiratory motion-induced error in the complex treatment process. RapidArc optimizes dose distribution via the combination of gantry rotation speed, dose rate, and the dynamic motion of a multi-leaf collimator (MLC). The gated RapidArc has great potential for dosimetric error than applying the gating method to three-dimensional conformal radiation therapy (3D CRT) and IMRT delivered with fixed gantry fields. [5] [6] [7] [8] [9] Many studies have been examined the errors that can potentially occur in gated RapidArc process and verified the effective delivery could be performed under a stable respiratory pattern.
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The respiratory pattern has many factors to keep a stable condition and a significant factor is gating window time length, which determines the total number of beam-on gates during In this study, the relationship between dosimetric errors in gated RapidArc and the number of stop-and-go gantry motions, which are inversely proportional to gating window time,
was assessed. Errors were analyzed to establish the proper criteria for setting gating window time.
Materials and Methods
Our study included 10 patients previously treated via gated was based on the pass rate calculated using the gamma evaluation method with a 3% dose difference, and a 3-mm distance to agreement criteria.
The Dynamic Platform Model 008PL system (CIRS Inc., Norfolk, VA), which can simulate respiratory motion, was used to set up accurate gating window times. The simulated respiratory cycle in this study was 4 sec, and beams were delivered and measured in three different conditions: no gating, a 1-sec gating window, and a 2-sec gating window. Our study used the Novalis Tx linear accelerator (Varian Medical Systems, Palo
Alto, CA) and, for gating, the Varian RPM system. The overall setup for measurements using the MapCHECK2 plan is shown in Fig. 1 .
Results
Example of the results obtained using the portal dosimetry plan and the MapCHECK2 plan are shown in Fig. 2 and Fig. 3 , respectively.
The dosimetric accuracy of RapidArc with no gating and 1-sec and 2-sec gating windows are shown in Table 1 . The pass rate worsened as gating window time decreased. between the measurement data and the planning data was lower when gating window time was longer in both DQA plans. In the MapCHECK2 plan, 2-sec gating had a lower average pass rate than no gating, but the difference was not significant (P=0.052). The average pass rate for 1-sec gating, however, was significantly lower than that of no gating (P＜10 −5 ), as well as that of 2-sec gating (P＜10 −5 ).
In the portal dosimetry plan, the average pass rates of both The difference between the dose calculated in a plan and the dose delivered to the patient via a gated RapidArc is mainly due to the interplay effects of organ motion during treatment. 11, 12) Court et al. 13) suggest that errors based on interplay effects cancel each other out when doses are delivered in many fractions and thus do not affect overall treatment accuracy.
Although interplay effects produce random errors owing to differences in the organ motions of different patients, our study shows that gating window time length is a determinant of systematic error and thus should be considered when planning gated RapidArc treatments.
A stable respiratory pattern is a basic prerequisite of accurate gated RapidArc treatment, and gating window time, which determines the number of stop-and-go motions, should be as long as possible. The suitable respiratory pattern for gated RapidArc includes a long flat respiratory phase in the region of end exhalation rather than a steep sinusoidal phase pattern.
Proper training of patients will enable stable, flat respiratory patterns that result in longer gating window times during gated RapidArc treatment.
Conclusion
Because the dosimetric accuracy of gated RapidArc increases as the number of gantry stop-and-go motions decreases, efforts should be made to increase gating window time during the RapidArc treatment process. Training patients to maintain a flat respiratory pattern during end exhalation will help increase gating window time in gated RapidArc.
